New treatment for hemophilia.
D003029:Coagulants / Q000627:therapeutic use*; D017277:Drug Approval; D005169:Factor VIII / Q000627:therapeutic use*; D006467:Hemophilia A / Q000188:drug therapy*; D006801:Humans; D011994:Recombinant Proteins / Q000627:therapeutic use
D003029:Coagulants; D011994:Recombinant Proteins; D005169:Factor VIII